In June 2018 DEA approved CBD in the form of Epidiolex, which is used for the treatment of seizures in children and adults.
Thereby CBD got reclassified from Schedule 1 drug, which is an illegal substance, to a Schedule 5 “controlled substance”
Since then many experiments and studies have demonstrated impressive effects of CBD, like anti-inflammatory and antioxidant ones. It has also proven to be helpful for anxiety, MS, different movements disorders and so on…
In the latest issue of Psychiatric Times former Surgeon General Joycelyn Elders and his colleagues argues that cannabis should be reclassified in order to let research develop. Having cannabis classified as a Schedule 1 drug is an obstacle to further research.
Endogene cannabis receptors found 1990
As a result of the current legislation, research has been slow, and the endogenous presence of a cannabinoid receptor in the human brain was not confirmed until 1990.
Since then much has been found out on the international field about the Endocannabinoid System (ECS) and its importance for human wellbeing.
Source: Is It Time to Legalize Cannabis? | Psychiatric Times